CD8A and non-small cell lung carcinoma: Analysis of CD103+CD8+ TRMs in a study of NSCLC revealed that their components contained TSTs that recognized TSAs, a subpopulation associated with improved survival and increased intraepithelial lymphocyte infiltration in patients with early-stage NSCLC (57).